Marpai, Inc. · OTC:MRAI
Marpai — Investor Presentation (February 2023)
18 slides from Marpai's investor presentation, Feb 1, 2023
Slide 1: Company Presentation February 2023
| MarpaiHealth.com (NASDAQ: MRAI) Company Presentation February 2023 Exhibit 99.1
Slide 2: Forward Looking Statements
| 2 Forward Looking Statements This presentation and the statements of representatives and partners of Marpai, Inc. (the “Company”) related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other U.S. Federal secu
Slide 3: Building the Health Plan of the Future
We use advanced AI, predictive analytics and SMART automation with the goal of reducing costs for employers while increasing health outcomes for their employees. Building the Health Plan of the Future HEALTH COSTS Proprietary and Confidential. © Marpai, Inc. 2023
Slide 4: Key Company Highlights
Key Company Highlights Tech and AI company disrupting the employer health benefit space We administer health plans for employers who directly pay for employee health benefits Trillion dollar industry segment2 Two acquisitions (Continental Benefits and Maestro) Revenue $0 to $30+ million in 3 years1
Slide 5: Company History
Feb 2019 April 2021 Oct 2021 Feb 2022 OCT 2022 NOV 2022 MAR 2023 2024 Founding 1st TPA Purchase IPO of $28.75 million 2nd TPA Purchase Hire Lutz Finger to expand product offering Restructuring Eliminating duplicate positions (NASDAQ: MRAI) Company History Gonen Antebi COO to transform operations
Slide 6: Total addressable market for TPA fees from self-insured employers
Total addressable market for TPA fees from self-insured employers3 % of employers offering self-insured health plans which requires a TPA – Third Party Administrator2 Spending by self-insured health plans is one-third of total healthcare in America1 Employer Health Plans Cover 165 MILLION Americans
Slide 7: Marpai and Maestro Health
) M A R PA Vee {ih} maestro health” MARPAI
Slide 8: Acquisition of Maestro Health Doubles Size of Marpai
Acquisition of Maestro Health Doubles Size of Marpai Combined Company Summary Employee Lives 40,000+ Annual Revenues $30+ million Cash on Balance Sheet $15+ million Healthcare Networks Aetna, CIGNA and more Value Added Services Marpai Rx, Clinical Care Management, Cost Containment Shared Focus Perso
Slide 9: More Solutions to Sell Existing and Future Clients
Represents Maestro Health’s existing services Represents Marpai’s existing services More Solutions to Sell Existing and Future Clients \ Marpai Cares AI-powered predictions and matching of members with proactive care Cost Containment Rx and out-of-network savings Care Management Nurses and clinical
Slide 10: Marpai Addresses the Full Spectrum of Care
Marpai Addresses the Full Spectrum of Care 1. Risk Stratified Care Management Enables Customized Treatment 2. Rising Risk: Maximizing the odds for care management 3. Marpai estimate Traditional Care Management Our focus is on the medium to rising risk population1,2,3 Value-Based Care Connect
Slide 11: Case Study: Savings of Self-insured vs. Fully Insured Plans
32% SAVINGS Per Employee Per Month (PEPM) by changing to Marpai’s self-insured plan1 Case Study: Savings Of Self-insured Vs. Fully Insured Plans Note: 1 $769 PEPM was United Healthcare’s renewal rate offer in for plan year 2018 to 2019; $524 PEPM was the client’s total cost of healthcare in year 1 w
Slide 12: New Product: Value-Based Care Connect
New Product: Value-Based Care Connect Our new product further monetizes our existing member base Marpai VB Care Connect is an aggregator of lives We enable our self-insured customers to work with value-based care (VBC) providers who would not have served our self-insured customers Our VBC partners t
Slide 13: New Product: Value-Based Care Connect
AI Using Claims & Other Data Matching Members to Proven Clinical Solutions Starting with Diabetes High Potential At-Risk Members At-Risk Members Diabetes Partner New Product: Value-Based Care Connect Leveraging our customer base and technology to market new value-based care treatments and Rx to redu
Slide 14: Value-Based Care Connect Case Study: Diabetes
94% 60% PROVEN TO REVERSE TYPE 2 DIABETES patients are off all diabetes-specific drugs and living diabetes-free after 1 year patients end or reduce insulin usage after 1 year Focus on whole member health Reduces excessive and avoidable care across all chronic conditions Coming in 2023 Cardiovascular
Slide 15: Capitalization
Marpai Health (NASDAQ: MRAI) Common Shares Outstanding 20,937,901 Warrants ($5.89 Weighted Average Exercise Price) 1,695,748 Options ($1.43 Weighted Average Exercise Price) 3,817,367 Fully Diluted Shares 26,451,016 Note: Figures as of December 19, 2022 Capitalization
Slide 16: Investment Summary
Predict Health States Prevent Costly Claims Organic + Acquisitions High Margin Claims Costs Highly Efficient Payer Investment Summary $22+ billion market opportunity addressed with highly differentiated AI products1 Source: 1 Company analysis based on estimated $44 Per Employee Per Month x 39M emplo
Slide 17: Seasoned Leadership Team
Seasoned Leadership Team Edmundo Gonzalez CEO Lutz Finger President, Product & Development Yoram Bibring CFO Yaron Eitan Chairman Damien Lamendola Director Mohsen Moazami Director Colleen DiClaudio Director Vincent Kane Director Yaron Eitan Chairman Edmundo Gonzalez CEO Seasoned Leadership Team Boar
Slide 18: What Will Be - Thank you